MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 65 filers reported holding MIRATI THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,164,836 | +34.1% | 164,482 | +11.2% | 0.00% | 0.0% |
| Q2 2023 | $5,342,471 | +34.3% | 147,868 | +38.2% | 0.00% | +100.0% |
| Q1 2023 | $3,979,449 | -44.7% | 107,032 | -32.6% | 0.00% | -50.0% |
| Q4 2022 | $7,192,147 | +380.4% | 158,732 | +640.1% | 0.00% | +100.0% |
| Q3 2022 | $1,497,000 | -55.2% | 21,446 | -56.9% | 0.00% | 0.0% |
| Q2 2022 | $3,340,000 | +406.1% | 49,762 | +519.6% | 0.00% | – |
| Q1 2022 | $660,000 | -90.1% | 8,031 | -82.4% | 0.00% | -100.0% |
| Q4 2021 | $6,695,000 | +19.4% | 45,638 | +43.9% | 0.00% | 0.0% |
| Q3 2021 | $5,608,000 | +581.4% | 31,706 | +522.2% | 0.00% | – |
| Q2 2021 | $823,000 | -52.1% | 5,096 | -49.2% | 0.00% | -100.0% |
| Q1 2021 | $1,718,000 | -45.3% | 10,032 | -29.8% | 0.00% | 0.0% |
| Q4 2020 | $3,138,000 | +50.4% | 14,290 | +13.7% | 0.00% | 0.0% |
| Q3 2020 | $2,087,000 | -26.0% | 12,565 | -49.2% | 0.00% | 0.0% |
| Q2 2020 | $2,822,000 | +133.0% | 24,713 | +56.9% | 0.00% | 0.0% |
| Q1 2020 | $1,211,000 | -47.7% | 15,754 | -12.4% | 0.00% | 0.0% |
| Q4 2019 | $2,317,000 | -64.1% | 17,980 | -78.3% | 0.00% | -50.0% |
| Q3 2019 | $6,455,000 | +205.2% | 82,856 | +303.5% | 0.00% | +100.0% |
| Q2 2019 | $2,115,000 | +857.0% | 20,534 | +579.0% | 0.00% | – |
| Q1 2019 | $221,000 | -97.0% | 3,024 | -98.3% | 0.00% | -100.0% |
| Q4 2018 | $7,418,000 | +442.6% | 174,881 | +502.5% | 0.00% | +200.0% |
| Q3 2018 | $1,367,000 | +1011.4% | 29,024 | +1061.0% | 0.00% | – |
| Q2 2018 | $123,000 | -93.4% | 2,500 | -95.9% | 0.00% | -100.0% |
| Q1 2018 | $1,855,000 | +303.3% | 60,443 | +139.8% | 0.00% | – |
| Q4 2017 | $460,000 | +169.0% | 25,210 | +72.8% | 0.00% | – |
| Q3 2017 | $171,000 | +83.9% | 14,590 | -42.3% | 0.00% | – |
| Q2 2017 | $93,000 | -20.5% | 25,291 | +12.4% | 0.00% | – |
| Q1 2017 | $117,000 | -10.0% | 22,495 | -17.4% | 0.00% | – |
| Q4 2016 | $130,000 | -8.5% | 27,240 | +26.7% | 0.00% | – |
| Q3 2016 | $142,000 | +18.3% | 21,503 | -2.2% | 0.00% | – |
| Q2 2016 | $120,000 | -72.0% | 21,997 | +9.6% | 0.00% | – |
| Q1 2016 | $429,000 | -65.3% | 20,066 | -48.7% | 0.00% | -100.0% |
| Q4 2015 | $1,235,000 | +114.8% | 39,095 | +134.4% | 0.00% | – |
| Q3 2015 | $575,000 | -0.2% | 16,682 | -8.9% | 0.00% | – |
| Q2 2015 | $576,000 | -0.9% | 18,318 | -7.6% | 0.00% | – |
| Q1 2015 | $581,000 | +166.5% | 19,831 | +68.6% | 0.00% | – |
| Q4 2014 | $218,000 | – | 11,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |